 | • レポートコード：QYR2104Z1333 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、134ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、シクロピロックスオラミンのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（クリーム調剤薬、温度、膣坐剤）、用途別市場規模（白癬（体）、水虫、白癬、癜風、カンジダアルビカンス、婦人科抗感染症製剤、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・シクロピロックスオラミンの市場動向 ・企業の競争状況、市場シェア ・シクロピロックスオラミンの種類別市場規模（クリーム調剤薬、温度、膣坐剤） ・シクロピロックスオラミンの用途別市場規模（白癬（体）、水虫、白癬、癜風、カンジダアルビカンス、婦人科抗感染症製剤、その他） ・シクロピロックスオラミンの北米市場規模2016-2027（アメリカ、カナダ） ・シクロピロックスオラミンのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・シクロピロックスオラミンのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・シクロピロックスオラミンの中南米市場規模2016-2027（メキシコ、ブラジル） ・シクロピロックスオラミンの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Bayer、Apotex Corporation、Fougera (Sandoz)、Medimetriks Pharmaceuticals、Taro Pharmaceuticals、Preferred Pharmaceuticals、Ingenus Pharmaceuticals、Alvogen (CVC Capital Partners and Temasek )、Acella Pharmaceuticals、Dr Marc's Manufacturing、Paddock Laboratories (Perrigo)、Sincerus、Glades Pharmaceuticals (GSK)、Sterimax、Guangzhou Kanghe Pharmaceutical、Tianjin Lisheng Pharmaceutical、Zhejiang Xianju Pharmaceutical、Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)） ・結論 |
Ciclopirox olamine (used in preparations called Batrafen, Loprox, Mycoster, Penlac and Stieprox) is a synthetic antifungal agent for topical dermatologic treatment of superficial mycoses. In particular, the agent is especially effective in treating Tinea versicolor.
Market Analysis and Insights: Global Ciclopirox Olamine Market
The global Ciclopirox Olamine market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Ciclopirox Olamine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Ciclopirox Olamine market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Ciclopirox Olamine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Ciclopirox Olamine market.
Global Ciclopirox Olamine Scope and Market Size
Ciclopirox Olamine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Ciclopirox Olamine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Cream Preparation
Temperture
Vaginal Suppository
Segment by Application
Ringworm Of The Body
Athlete’S Foot
Tinea
Tinea Versicolor
Candida Albicans
Gynecological Anti-Infection Preparation
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Bayer
Apotex Corporation
Fougera (Sandoz)
Medimetriks Pharmaceuticals
Taro Pharmaceuticals
Preferred Pharmaceuticals
Ingenus Pharmaceuticals
Alvogen (CVC Capital Partners and Temasek )
Acella Pharmaceuticals
Dr Marc’s Manufacturing
Paddock Laboratories (Perrigo)
Sincerus
Glades Pharmaceuticals (GSK)
Sterimax
Guangzhou Kanghe Pharmaceutical
Tianjin Lisheng Pharmaceutical
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ciclopirox Olamine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Cream Preparation
1.2.3 Temperture
1.2.4 Vaginal Suppository
1.3 Market by Application
1.3.1 Global Ciclopirox Olamine Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Ringworm Of The Body
1.3.3 Athlete’S Foot
1.3.4 Tinea
1.3.5 Tinea Versicolor
1.3.6 Candida Albicans
1.3.7 Gynecological Anti-Infection Preparation
1.3.8 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Ciclopirox Olamine Market Perspective (2016-2027)
2.2 Ciclopirox Olamine Growth Trends by Regions
2.2.1 Ciclopirox Olamine Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Ciclopirox Olamine Historic Market Share by Regions (2016-2021)
2.2.3 Ciclopirox Olamine Forecasted Market Size by Regions (2022-2027)
2.3 Ciclopirox Olamine Industry Dynamic
2.3.1 Ciclopirox Olamine Market Trends
2.3.2 Ciclopirox Olamine Market Drivers
2.3.3 Ciclopirox Olamine Market Challenges
2.3.4 Ciclopirox Olamine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Ciclopirox Olamine Players by Revenue
3.1.1 Global Top Ciclopirox Olamine Players by Revenue (2016-2021)
3.1.2 Global Ciclopirox Olamine Revenue Market Share by Players (2016-2021)
3.2 Global Ciclopirox Olamine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Ciclopirox Olamine Revenue
3.4 Global Ciclopirox Olamine Market Concentration Ratio
3.4.1 Global Ciclopirox Olamine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ciclopirox Olamine Revenue in 2020
3.5 Ciclopirox Olamine Key Players Head office and Area Served
3.6 Key Players Ciclopirox Olamine Product Solution and Service
3.7 Date of Enter into Ciclopirox Olamine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Ciclopirox Olamine Breakdown Data by Type
4.1 Global Ciclopirox Olamine Historic Market Size by Type (2016-2021)
4.2 Global Ciclopirox Olamine Forecasted Market Size by Type (2022-2027)
5 Ciclopirox Olamine Breakdown Data by Application
5.1 Global Ciclopirox Olamine Historic Market Size by Application (2016-2021)
5.2 Global Ciclopirox Olamine Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Ciclopirox Olamine Market Size (2016-2027)
6.2 North America Ciclopirox Olamine Market Size by Type
6.2.1 North America Ciclopirox Olamine Market Size by Type (2016-2021)
6.2.2 North America Ciclopirox Olamine Market Size by Type (2022-2027)
6.2.3 North America Ciclopirox Olamine Market Size by Type (2016-2027)
6.3 North America Ciclopirox Olamine Market Size by Application
6.3.1 North America Ciclopirox Olamine Market Size by Application (2016-2021)
6.3.2 North America Ciclopirox Olamine Market Size by Application (2022-2027)
6.3.3 North America Ciclopirox Olamine Market Size by Application (2016-2027)
6.4 North America Ciclopirox Olamine Market Size by Country
6.4.1 North America Ciclopirox Olamine Market Size by Country (2016-2021)
6.4.2 North America Ciclopirox Olamine Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Ciclopirox Olamine Market Size (2016-2027)
7.2 Europe Ciclopirox Olamine Market Size by Type
7.2.1 Europe Ciclopirox Olamine Market Size by Type (2016-2021)
7.2.2 Europe Ciclopirox Olamine Market Size by Type (2022-2027)
7.2.3 Europe Ciclopirox Olamine Market Size by Type (2016-2027)
7.3 Europe Ciclopirox Olamine Market Size by Application
7.3.1 Europe Ciclopirox Olamine Market Size by Application (2016-2021)
7.3.2 Europe Ciclopirox Olamine Market Size by Application (2022-2027)
7.3.3 Europe Ciclopirox Olamine Market Size by Application (2016-2027)
7.4 Europe Ciclopirox Olamine Market Size by Country
7.4.1 Europe Ciclopirox Olamine Market Size by Country (2016-2021)
7.4.2 Europe Ciclopirox Olamine Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Ciclopirox Olamine Market Size (2016-2027)
8.2 Asia-Pacific Ciclopirox Olamine Market Size by Type
8.2.1 Asia-Pacific Ciclopirox Olamine Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Ciclopirox Olamine Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Ciclopirox Olamine Market Size by Type (2016-2027)
8.3 Asia-Pacific Ciclopirox Olamine Market Size by Application
8.3.1 Asia-Pacific Ciclopirox Olamine Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Ciclopirox Olamine Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Ciclopirox Olamine Market Size by Application (2016-2027)
8.4 Asia-Pacific Ciclopirox Olamine Market Size by Region
8.4.1 Asia-Pacific Ciclopirox Olamine Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Ciclopirox Olamine Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Ciclopirox Olamine Market Size (2016-2027)
9.2 Latin America Ciclopirox Olamine Market Size by Type
9.2.1 Latin America Ciclopirox Olamine Market Size by Type (2016-2021)
9.2.2 Latin America Ciclopirox Olamine Market Size by Type (2022-2027)
9.2.3 Latin America Ciclopirox Olamine Market Size by Type (2016-2027)
9.3 Latin America Ciclopirox Olamine Market Size by Application
9.3.1 Latin America Ciclopirox Olamine Market Size by Application (2016-2021)
9.3.2 Latin America Ciclopirox Olamine Market Size by Application (2022-2027)
9.3.3 Latin America Ciclopirox Olamine Market Size by Application (2016-2027)
9.4 Latin America Ciclopirox Olamine Market Size by Country
9.4.1 Latin America Ciclopirox Olamine Market Size by Country (2016-2021)
9.4.2 Latin America Ciclopirox Olamine Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Ciclopirox Olamine Market Size (2016-2027)
10.2 Middle East & Africa Ciclopirox Olamine Market Size by Type
10.2.1 Middle East & Africa Ciclopirox Olamine Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Ciclopirox Olamine Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Ciclopirox Olamine Market Size by Type (2016-2027)
10.3 Middle East & Africa Ciclopirox Olamine Market Size by Application
10.3.1 Middle East & Africa Ciclopirox Olamine Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Ciclopirox Olamine Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Ciclopirox Olamine Market Size by Application (2016-2027)
10.4 Middle East & Africa Ciclopirox Olamine Market Size by Country
10.4.1 Middle East & Africa Ciclopirox Olamine Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Ciclopirox Olamine Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Ciclopirox Olamine Introduction
11.1.4 Bayer Revenue in Ciclopirox Olamine Business (2016-2021)
11.1.5 Bayer Recent Development
11.2 Apotex Corporation
11.2.1 Apotex Corporation Company Details
11.2.2 Apotex Corporation Business Overview
11.2.3 Apotex Corporation Ciclopirox Olamine Introduction
11.2.4 Apotex Corporation Revenue in Ciclopirox Olamine Business (2016-2021)
11.2.5 Apotex Corporation Recent Development
11.3 Fougera (Sandoz)
11.3.1 Fougera (Sandoz) Company Details
11.3.2 Fougera (Sandoz) Business Overview
11.3.3 Fougera (Sandoz) Ciclopirox Olamine Introduction
11.3.4 Fougera (Sandoz) Revenue in Ciclopirox Olamine Business (2016-2021)
11.3.5 Fougera (Sandoz) Recent Development
11.4 Medimetriks Pharmaceuticals
11.4.1 Medimetriks Pharmaceuticals Company Details
11.4.2 Medimetriks Pharmaceuticals Business Overview
11.4.3 Medimetriks Pharmaceuticals Ciclopirox Olamine Introduction
11.4.4 Medimetriks Pharmaceuticals Revenue in Ciclopirox Olamine Business (2016-2021)
11.4.5 Medimetriks Pharmaceuticals Recent Development
11.5 Taro Pharmaceuticals
11.5.1 Taro Pharmaceuticals Company Details
11.5.2 Taro Pharmaceuticals Business Overview
11.5.3 Taro Pharmaceuticals Ciclopirox Olamine Introduction
11.5.4 Taro Pharmaceuticals Revenue in Ciclopirox Olamine Business (2016-2021)
11.5.5 Taro Pharmaceuticals Recent Development
11.6 Preferred Pharmaceuticals
11.6.1 Preferred Pharmaceuticals Company Details
11.6.2 Preferred Pharmaceuticals Business Overview
11.6.3 Preferred Pharmaceuticals Ciclopirox Olamine Introduction
11.6.4 Preferred Pharmaceuticals Revenue in Ciclopirox Olamine Business (2016-2021)
11.6.5 Preferred Pharmaceuticals Recent Development
11.7 Ingenus Pharmaceuticals
11.7.1 Ingenus Pharmaceuticals Company Details
11.7.2 Ingenus Pharmaceuticals Business Overview
11.7.3 Ingenus Pharmaceuticals Ciclopirox Olamine Introduction
11.7.4 Ingenus Pharmaceuticals Revenue in Ciclopirox Olamine Business (2016-2021)
11.7.5 Ingenus Pharmaceuticals Recent Development
11.8 Alvogen (CVC Capital Partners and Temasek )
11.8.1 Alvogen (CVC Capital Partners and Temasek ) Company Details
11.8.2 Alvogen (CVC Capital Partners and Temasek ) Business Overview
11.8.3 Alvogen (CVC Capital Partners and Temasek ) Ciclopirox Olamine Introduction
11.8.4 Alvogen (CVC Capital Partners and Temasek ) Revenue in Ciclopirox Olamine Business (2016-2021)
11.8.5 Alvogen (CVC Capital Partners and Temasek ) Recent Development
11.9 Acella Pharmaceuticals
11.9.1 Acella Pharmaceuticals Company Details
11.9.2 Acella Pharmaceuticals Business Overview
11.9.3 Acella Pharmaceuticals Ciclopirox Olamine Introduction
11.9.4 Acella Pharmaceuticals Revenue in Ciclopirox Olamine Business (2016-2021)
11.9.5 Acella Pharmaceuticals Recent Development
11.10 Dr Marc’s Manufacturing
11.10.1 Dr Marc’s Manufacturing Company Details
11.10.2 Dr Marc’s Manufacturing Business Overview
11.10.3 Dr Marc’s Manufacturing Ciclopirox Olamine Introduction
11.10.4 Dr Marc’s Manufacturing Revenue in Ciclopirox Olamine Business (2016-2021)
11.10.5 Dr Marc’s Manufacturing Recent Development
11.11 Paddock Laboratories (Perrigo)
11.11.1 Paddock Laboratories (Perrigo) Company Details
11.11.2 Paddock Laboratories (Perrigo) Business Overview
11.11.3 Paddock Laboratories (Perrigo) Ciclopirox Olamine Introduction
11.11.4 Paddock Laboratories (Perrigo) Revenue in Ciclopirox Olamine Business (2016-2021)
11.11.5 Paddock Laboratories (Perrigo) Recent Development
11.12 Sincerus
11.12.1 Sincerus Company Details
11.12.2 Sincerus Business Overview
11.12.3 Sincerus Ciclopirox Olamine Introduction
11.12.4 Sincerus Revenue in Ciclopirox Olamine Business (2016-2021)
11.12.5 Sincerus Recent Development
11.13 Glades Pharmaceuticals (GSK)
11.13.1 Glades Pharmaceuticals (GSK) Company Details
11.13.2 Glades Pharmaceuticals (GSK) Business Overview
11.13.3 Glades Pharmaceuticals (GSK) Ciclopirox Olamine Introduction
11.13.4 Glades Pharmaceuticals (GSK) Revenue in Ciclopirox Olamine Business (2016-2021)
11.13.5 Glades Pharmaceuticals (GSK) Recent Development
11.14 Sterimax
11.14.1 Sterimax Company Details
11.14.2 Sterimax Business Overview
11.14.3 Sterimax Ciclopirox Olamine Introduction
11.14.4 Sterimax Revenue in Ciclopirox Olamine Business (2016-2021)
11.14.5 Sterimax Recent Development
11.15 Guangzhou Kanghe Pharmaceutical
11.15.1 Guangzhou Kanghe Pharmaceutical Company Details
11.15.2 Guangzhou Kanghe Pharmaceutical Business Overview
11.15.3 Guangzhou Kanghe Pharmaceutical Ciclopirox Olamine Introduction
11.15.4 Guangzhou Kanghe Pharmaceutical Revenue in Ciclopirox Olamine Business (2016-2021)
11.15.5 Guangzhou Kanghe Pharmaceutical Recent Development
11.16 Tianjin Lisheng Pharmaceutical
11.16.1 Tianjin Lisheng Pharmaceutical Company Details
11.16.2 Tianjin Lisheng Pharmaceutical Business Overview
11.16.3 Tianjin Lisheng Pharmaceutical Ciclopirox Olamine Introduction
11.16.4 Tianjin Lisheng Pharmaceutical Revenue in Ciclopirox Olamine Business (2016-2021)
11.16.5 Tianjin Lisheng Pharmaceutical Recent Development
11.17 Zhejiang Xianju Pharmaceutical
11.17.1 Zhejiang Xianju Pharmaceutical Company Details
11.17.2 Zhejiang Xianju Pharmaceutical Business Overview
11.17.3 Zhejiang Xianju Pharmaceutical Ciclopirox Olamine Introduction
11.17.4 Zhejiang Xianju Pharmaceutical Revenue in Ciclopirox Olamine Business (2016-2021)
11.17.5 Zhejiang Xianju Pharmaceutical Recent Development
11.18 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding)
11.18.1 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Company Details
11.18.2 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Business Overview
11.18.3 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Ciclopirox Olamine Introduction
11.18.4 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Revenue in Ciclopirox Olamine Business (2016-2021)
11.18.5 Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Ciclopirox Olamine Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Cream Preparation
Table 3. Key Players of Temperture
Table 4. Key Players of Vaginal Suppository
Table 5. Global Ciclopirox Olamine Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Ciclopirox Olamine Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Ciclopirox Olamine Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Ciclopirox Olamine Market Share by Regions (2016-2021)
Table 9. Global Ciclopirox Olamine Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Ciclopirox Olamine Market Share by Regions (2022-2027)
Table 11. Ciclopirox Olamine Market Trends
Table 12. Ciclopirox Olamine Market Drivers
Table 13. Ciclopirox Olamine Market Challenges
Table 14. Ciclopirox Olamine Market Restraints
Table 15. Global Ciclopirox Olamine Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Ciclopirox Olamine Market Share by Players (2016-2021)
Table 17. Global Top Ciclopirox Olamine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ciclopirox Olamine as of 2020)
Table 18. Ranking of Global Top Ciclopirox Olamine Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Ciclopirox Olamine Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Ciclopirox Olamine Product Solution and Service
Table 22. Date of Enter into Ciclopirox Olamine Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Ciclopirox Olamine Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Ciclopirox Olamine Revenue Market Share by Type (2016-2021)
Table 26. Global Ciclopirox Olamine Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Ciclopirox Olamine Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Ciclopirox Olamine Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Ciclopirox Olamine Revenue Market Share by Application (2016-2021)
Table 30. Global Ciclopirox Olamine Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Ciclopirox Olamine Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Ciclopirox Olamine Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Ciclopirox Olamine Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Ciclopirox Olamine Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Ciclopirox Olamine Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Ciclopirox Olamine Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Ciclopirox Olamine Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Ciclopirox Olamine Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Ciclopirox Olamine Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Ciclopirox Olamine Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Ciclopirox Olamine Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Ciclopirox Olamine Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Ciclopirox Olamine Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Ciclopirox Olamine Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Ciclopirox Olamine Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Ciclopirox Olamine Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Ciclopirox Olamine Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Ciclopirox Olamine Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Ciclopirox Olamine Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Ciclopirox Olamine Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Ciclopirox Olamine Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Ciclopirox Olamine Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Ciclopirox Olamine Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Ciclopirox Olamine Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Ciclopirox Olamine Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Ciclopirox Olamine Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Ciclopirox Olamine Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Ciclopirox Olamine Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Ciclopirox Olamine Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Ciclopirox Olamine Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Ciclopirox Olamine Market Size by Country (2022-2027) & (US$ Million)
Table 62. Bayer Company Details
Table 63. Bayer Business Overview
Table 64. Bayer Ciclopirox Olamine Product
Table 65. Bayer Revenue in Ciclopirox Olamine Business (2016-2021) & (US$ Million)
Table 66. Bayer Recent Development
Table 67. Apotex Corporation Company Details
Table 68. Apotex Corporation Business Overview
Table 69. Apotex Corporation Ciclopirox Olamine Product
Table 70. Apotex Corporation Revenue in Ciclopirox Olamine Business (2016-2021) & (US$ Million)
Table 71. Apotex Corporation Recent Development
Table 72. Fougera (Sandoz) Company Details
Table 73. Fougera (Sandoz) Business Overview
Table 74. Fougera (Sandoz) Ciclopirox Olamine Product
Table 75. Fougera (Sandoz) Revenue in Ciclopirox Olamine Business (2016-2021) & (US$ Million)
Table 76. Fougera (Sandoz) Recent Development
Table 77. Medimetriks Pharmaceuticals Company Details
Table 78. Medimetriks Pharmaceuticals Business Overview
Table 79. Medimetriks Pharmaceuticals Ciclopirox Olamine Product
Table 80. Medimetriks Pharmaceuticals Revenue in Ciclopirox Olamine Business (2016-2021) & (US$ Million)
Table 81. Medimetriks Pharmaceuticals Recent Development
Table 82. Taro Pharmaceuticals Company Details
Table 83. Taro Pharmaceuticals Business Overview
Table 84. Taro Pharmaceuticals Ciclopirox Olamine Product
Table 85. Taro Pharmaceuticals Revenue in Ciclopirox Olamine Business (2016-2021) & (US$ Million)
Table 86. Taro Pharmaceuticals Recent Development
Table 87. Preferred Pharmaceuticals Company Details
Table 88. Preferred Pharmaceuticals Business Overview
Table 89. Preferred Pharmaceuticals Ciclopirox Olamine Product
Table 90. Preferred Pharmaceuticals Revenue in Ciclopirox Olamine Business (2016-2021) & (US$ Million)
Table 91. Preferred Pharmaceuticals Recent Development
Table 92. Ingenus Pharmaceuticals Company Details
Table 93. Ingenus Pharmaceuticals Business Overview
Table 94. Ingenus Pharmaceuticals Ciclopirox Olamine Product
Table 95. Ingenus Pharmaceuticals Revenue in Ciclopirox Olamine Business (2016-2021) & (US$ Million)
Table 96. Ingenus Pharmaceuticals Recent Development
Table 97. Alvogen (CVC Capital Partners and Temasek ) Company Details
Table 98. Alvogen (CVC Capital Partners and Temasek ) Business Overview
Table 99. Alvogen (CVC Capital Partners and Temasek ) Revenue in Ciclopirox Olamine Business (2016-2021) & (US$ Million)
Table 100. Alvogen (CVC Capital Partners and Temasek ) Recent Development
Table 101. Acella Pharmaceuticals Company Details
Table 102. Acella Pharmaceuticals Business Overview
Table 103. Acella Pharmaceuticals Ciclopirox Olamine Product
Table 104. Acella Pharmaceuticals Revenue in Ciclopirox Olamine Business (2016-2021) & (US$ Million)
Table 105. Acella Pharmaceuticals Recent Development
Table 106. Dr Marc's Manufacturing Company Details
Table 107. Dr Marc's Manufacturing Business Overview
Table 108. Dr Marc's Manufacturing Ciclopirox Olamine Product
Table 109. Dr Marc's Manufacturing Revenue in Ciclopirox Olamine Business (2016-2021) & (US$ Million)
Table 110. Dr Marc's Manufacturing Recent Development
Table 111. Paddock Laboratories (Perrigo) Company Details
Table 112. Paddock Laboratories (Perrigo) Business Overview
Table 113. Paddock Laboratories (Perrigo) Ciclopirox Olamine Product
Table 114. Paddock Laboratories (Perrigo) Revenue in Ciclopirox Olamine Business (2016-2021) & (US$ Million)
Table 115. Paddock Laboratories (Perrigo) Recent Development
Table 116. Sincerus Company Details
Table 117. Sincerus Business Overview
Table 118. Sincerus Ciclopirox Olamine Product
Table 119. Sincerus Revenue in Ciclopirox Olamine Business (2016-2021) & (US$ Million)
Table 120. Sincerus Recent Development
Table 121. Glades Pharmaceuticals (GSK) Company Details
Table 122. Glades Pharmaceuticals (GSK) Business Overview
Table 123. Glades Pharmaceuticals (GSK) Ciclopirox Olamine Product
Table 124. Glades Pharmaceuticals (GSK) Revenue in Ciclopirox Olamine Business (2016-2021) & (US$ Million)
Table 125. Glades Pharmaceuticals (GSK) Recent Development
Table 126. Sterimax Company Details
Table 127. Sterimax Business Overview
Table 128. Sterimax Ciclopirox Olamine Product
Table 129. Sterimax Revenue in Ciclopirox Olamine Business (2016-2021) & (US$ Million)
Table 130. Sterimax Recent Development
Table 131. Guangzhou Kanghe Pharmaceutical Company Details
Table 132. Guangzhou Kanghe Pharmaceutical Business Overview
Table 133. Guangzhou Kanghe Pharmaceutical Ciclopirox Olamine Product
Table 134. Guangzhou Kanghe Pharmaceutical Revenue in Ciclopirox Olamine Business (2016-2021) & (US$ Million)
Table 135. Guangzhou Kanghe Pharmaceutical Recent Development
Table 136. Tianjin Lisheng Pharmaceutical Company Details
Table 137. Tianjin Lisheng Pharmaceutical Business Overview
Table 138. Tianjin Lisheng Pharmaceutical Ciclopirox Olamine Product
Table 139. Tianjin Lisheng Pharmaceutical Revenue in Ciclopirox Olamine Business (2016-2021) & (US$ Million)
Table 140. Tianjin Lisheng Pharmaceutical Recent Development
Table 141. Zhejiang Xianju Pharmaceutical Company Details
Table 142. Zhejiang Xianju Pharmaceutical Business Overview
Table 143. Zhejiang Xianju Pharmaceutical Ciclopirox Olamine Product
Table 144. Zhejiang Xianju Pharmaceutical Revenue in Ciclopirox Olamine Business (2016-2021) & (US$ Million)
Table 145. Zhejiang Xianju Pharmaceutical Recent Development
Table 146. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Company Details
Table 147. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Business Overview
Table 148. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Ciclopirox Olamine Product
Table 149. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Revenue in Ciclopirox Olamine Business (2016-2021) & (US$ Million)
Table 150. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Recent Development
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Ciclopirox Olamine Market Share by Type: 2020 VS 2027
Figure 2. Cream Preparation Features
Figure 3. Temperture Features
Figure 4. Vaginal Suppository Features
Figure 5. Global Ciclopirox Olamine Market Share by Application: 2020 VS 2027
Figure 6. Ringworm Of The Body Case Studies
Figure 7. Athlete'S Foot Case Studies
Figure 8. Tinea Case Studies
Figure 9. Tinea Versicolor Case Studies
Figure 10. Candida Albicans Case Studies
Figure 11. Gynecological Anti-Infection Preparation Case Studies
Figure 12. Other Case Studies
Figure 13. Ciclopirox Olamine Report Years Considered
Figure 14. Global Ciclopirox Olamine Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Ciclopirox Olamine Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Ciclopirox Olamine Market Share by Regions: 2020 VS 2027
Figure 17. Global Ciclopirox Olamine Market Share by Regions (2022-2027)
Figure 18. Global Ciclopirox Olamine Market Share by Players in 2020
Figure 19. Global Top Ciclopirox Olamine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ciclopirox Olamine as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Ciclopirox Olamine Revenue in 2020
Figure 21. Global Ciclopirox Olamine Revenue Market Share by Type (2016-2021)
Figure 22. Global Ciclopirox Olamine Revenue Market Share by Type (2022-2027)
Figure 23. North America Ciclopirox Olamine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Ciclopirox Olamine Market Share by Type (2016-2027)
Figure 25. North America Ciclopirox Olamine Market Share by Application (2016-2027)
Figure 26. North America Ciclopirox Olamine Market Share by Country (2016-2027)
Figure 27. United States Ciclopirox Olamine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Ciclopirox Olamine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Ciclopirox Olamine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Ciclopirox Olamine Market Share by Type (2016-2027)
Figure 31. Europe Ciclopirox Olamine Market Share by Application (2016-2027)
Figure 32. Europe Ciclopirox Olamine Market Share by Country (2016-2027)
Figure 33. Germany Ciclopirox Olamine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Ciclopirox Olamine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Ciclopirox Olamine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Ciclopirox Olamine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Ciclopirox Olamine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Ciclopirox Olamine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Ciclopirox Olamine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Ciclopirox Olamine Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Ciclopirox Olamine Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Ciclopirox Olamine Market Share by Region (2016-2027)
Figure 43. China Ciclopirox Olamine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Ciclopirox Olamine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Ciclopirox Olamine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Ciclopirox Olamine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Ciclopirox Olamine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Ciclopirox Olamine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Ciclopirox Olamine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Ciclopirox Olamine Market Share by Type (2016-2027)
Figure 51. Latin America Ciclopirox Olamine Market Share by Application (2016-2027)
Figure 52. Latin America Ciclopirox Olamine Market Share by Country (2016-2027)
Figure 53. Mexico Ciclopirox Olamine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Ciclopirox Olamine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Ciclopirox Olamine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Ciclopirox Olamine Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Ciclopirox Olamine Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Ciclopirox Olamine Market Share by Country (2016-2027)
Figure 59. Turkey Ciclopirox Olamine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Ciclopirox Olamine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Ciclopirox Olamine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Bayer Revenue Growth Rate in Ciclopirox Olamine Business (2016-2021)
Figure 63. Apotex Corporation Revenue Growth Rate in Ciclopirox Olamine Business (2016-2021)
Figure 64. Fougera (Sandoz) Revenue Growth Rate in Ciclopirox Olamine Business (2016-2021)
Figure 65. Medimetriks Pharmaceuticals Revenue Growth Rate in Ciclopirox Olamine Business (2016-2021)
Figure 66. Taro Pharmaceuticals Revenue Growth Rate in Ciclopirox Olamine Business (2016-2021)
Figure 67. Preferred Pharmaceuticals Revenue Growth Rate in Ciclopirox Olamine Business (2016-2021)
Figure 68. Ingenus Pharmaceuticals Revenue Growth Rate in Ciclopirox Olamine Business (2016-2021)
Figure 69. Alvogen (CVC Capital Partners and Temasek ) Revenue Growth Rate in Ciclopirox Olamine Business (2016-2021)
Figure 70. Acella Pharmaceuticals Revenue Growth Rate in Ciclopirox Olamine Business (2016-2021)
Figure 71. Dr Marc's Manufacturing Revenue Growth Rate in Ciclopirox Olamine Business (2016-2021)
Figure 72. Paddock Laboratories (Perrigo) Revenue Growth Rate in Ciclopirox Olamine Business (2016-2021)
Figure 73. Sincerus Revenue Growth Rate in Ciclopirox Olamine Business (2016-2021)
Figure 74. Glades Pharmaceuticals (GSK) Revenue Growth Rate in Ciclopirox Olamine Business (2016-2021)
Figure 75. Sterimax Revenue Growth Rate in Ciclopirox Olamine Business (2016-2021)
Figure 76. Guangzhou Kanghe Pharmaceutical Revenue Growth Rate in Ciclopirox Olamine Business (2016-2021)
Figure 77. Tianjin Lisheng Pharmaceutical Revenue Growth Rate in Ciclopirox Olamine Business (2016-2021)
Figure 78. Zhejiang Xianju Pharmaceutical Revenue Growth Rate in Ciclopirox Olamine Business (2016-2021)
Figure 79. Shanghai Sine Pharmaceutical Laboratories (Shanghai Pharmaceuticals Holding) Revenue Growth Rate in Ciclopirox Olamine Business (2016-2021)
Figure 80. Bottom-up and Top-down Approaches for This Report
Figure 81. Data Triangulation
Figure 82. Key Executives Interviewed
世界のシクロピロックスオラミン市場規模・現状・予測（2021年-2027年） Ciclopirox olamine (used in preparations called Batrafen, Loprox, Mycoster, Penlac and Stieprox) is a synthetic antifungal agent for topical dermatologic treatment of superficial mycoses. In particular, the agent is especially effective in treating Tinea versicolor. Market Analysis and Insights: Glo…- 世界の癜風トリートメント市場規模・現状・予測（2021年-2027年） Tinea Versicolor is one of the common types of skin infection. It also called as pityriasis versicolor. In this condition, small and discolored patches of skin occur, mostly affecting the shoulders and trunk. Market Analysis and Insights: Global Tinea Versicolor Treatment Market The global Tinea Ver…
- 世界の水虫（足白癬）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Athletes Foot (Tinea pedis) Treatment Market The global Athletes Foot (Tinea pedis) Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and…
- 世界の水虫（足白癬）治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Athletes Foot (Tinea pedis) Treatment Market The global Athletes Foot (Tinea pedis) Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and…
- 世界のDNAライブラリープレパレーションキット市場規模・現状・予測（2021年-2027年） DNA library preparation kit is collectively set of improved reagents which are used to convert the small amount of DNA into indexed libraries. DNA library kits are used in next-generation sequencing for conversion of small amount of DNA. DNA library preparation kits are developed on the basis of Tn5…